Action 000623 JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jilin Aodong Pharmaceutical Group Co., Ltd.

Actions

000623

CNE000000719

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 15/05/2024 		Varia. 5j. Varia. 1 janv.
14,85 CNY -1,39% Graphique intraday de Jilin Aodong Pharmaceutical Group Co., Ltd. -0,93% -1,92%
29/04 Jilin Aodong Pharmaceutical Group Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
17/04 Les bénéfices d'Aodong Medicine pour 2023 en baisse de 18% ; les revenus en hausse de 20% MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on September 21, 2023, has closed with 9,015,780 shares, representing 0.8% for CNY 150 million.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Chinese listed firms used endangered animal parts as ingredients -report
Three listed Chinese firms used endangered animal parts as ingredients- report
Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd.
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 6, 2022, has expired.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 000623
  4. Actualités Jilin Aodong Pharmaceutical Group Co., Ltd.
  5. Autres langues